Medical Mysteries Revealed: Unraveling the Secrets of Rare and Undiagnosed Diseases
Millions of people around the world suffer from rare and undiagnosed diseases, often leading to years of frustration, uncertainty, and distress. This session will explore the latest approaches and tools for diagnosing and managing rare diseases. It will delve into cutting-edge genetic-sequencing technologies and advanced data analytics that can assist and guide diagnosis. Participants will also learn about interdisciplinary teams and patient advocacy and the impact they have on solving these complex medical problems.
Category
  • Disease management
  • Rare diseases
Format
  • Webcasts
Credits
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 CDR - Dietitians
  • 1.25 ASWB - Social Workers
New and Emerging Approaches to Diabetes Management
This activity will outline the current state of diabetes therapy and review recent data regarding the effectiveness of remission-related approaches. It will also discuss available and emerging AI applications that can assist patients with glycemic control.
Category
  • Disease management
Format
  • Webcasts
Credits
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
Chronic Kidney Disease: Advancing Strategies to Prevent Progression
Chronic kidney disease (CKD), typically caused by diabetes and hypertension, affects 15% of US adults and continues to increase with the rising prevalence of these conditions. Increased health care utilization and high morbidity/mortality rates are associated with the progression of CKD to kidney failure with comorbid cardiovascular disease, anemia and bone disease. This session will examine the current state of care for CKD, including recent advancements and interventions that can slow CKD progression and preserve kidney function and strategies to optimize care pathways for managing CKD and its common comorbidities.
Category
  • Disease management
Format
  • Webcasts
Credits
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
Exploring Opioid Crisis Dynamics: New Perspectives and Strategies
This activity will focus on enhancing our understanding of the current opioid crisis and will explore new angles and address current concerns, including the use of over-the-counter intranasal naloxone, the evolving landscape of opioids with a focus on fentanyl, the intersection between suicide and opioid overdoses, the significance of the new 988 helpline in the crisis, and the viability of home-based detox startups. Strategies to effectively address the ongoing challenges of the opioid crisis will be discussed.
Category
  • Disease management
Format
  • Webcasts
Credits
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
The WISDOM Study: A Personalized Approach to Breast Cancer Screening
This activity aims to explore best practices in cancer screening and shed light on the groundbreaking WISDOM Study, which is revolutionizing our approach to screening by testing a personalized precision-medicine method based on individual risk factors for breast cancer in contrast to traditional annual mammograms. Participants will learn how this alternative approach differs from the current “one-size-fits-all” guideline-based method and discuss its potential to significantly improve the effectiveness of screening.
Category
  • Disease management
  • Oncology
Format
  • Webcasts
Credits
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
The Battle Against Alzheimer’s Disease: New Advancements, Treatments and Hope
Alzheimer’s disease (AD) is a pressing public health crisis, affecting more than 6 million people in the U.S. and increasing in prevalence with the aging population. Join us in exploring the latest advances in AD diagnosis and management, including biomarkers, imaging techniques and cognitive assessments. Emerging pharmacological therapies that target the underlying disease and novel approaches to optimizing patient care will be highlighted.
Category
  • Disease management
Format
  • Webcasts
Credits
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
Unraveling the Past, Paving the Way for the Future—Rethinking Pulmonary Function Tests Beyond Race
Pulmonary function tests (PFTs) are commonly utilized for the diagnosis and ongoing monitoring of pulmonary conditions. However, the inclusion of race in the reporting and interpretation of PFT results introduces the potential to contribute to health disparities and amplify race-based health inequities. This activity aims to enhance participants’ comprehension of race-based adjustments in clinical algorithms and increase competency in race-neutral and impartial interpretation of PFTs. The faculty speaker for this webcast, Dr. Nirav Bhakta, served as the co-chair of the American Thoracic Society (ATS) workshop responsible for shaping the 2023 ATS statement on race in PFT interpretation. Drawing upon his extensive expertise as a pulmonologist and his pivotal role in the formulation of these new ATS guidelines, Dr. Bhakta will delve into the historical context behind race-specific PFTs, address the rationale behind the shift and review the pivotal aspects and implications of adopting a race-neutral approach.
Category
  • Disease management
  • Health equity
Format
  • Online Education
Credits
  • 1.00 AAFP - Family Physicians
  • 1.00 ABIM MOC - Physicians
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
Autism Spectrum Disorder: Treatment Options for Children
This activity will focus on various evidence-based treatments for autism spectrum disorder (ASD), including psychopharmacology, complementary and alternative medicine (CAM), and intensive behavioral therapies, including applied behavioral analysis (ABA). The significance of early intervention services and educational support beyond preschool will be highlighted. In addition, the benefits of supportive practices such as mindfulness and stress management for caregivers will be explored.
Category
  • Behavioral health
Format
  • Webcasts
Credits
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 BACB – ABA Behavior Analysts
  • 1.00 ASWB - Social Workers
Autism Spectrum Disorder: Overview, Screening, Diagnosis and Treatment Planning
This activity will provide an overview of neurodiversity and examine the essential features of autism spectrum disorder (ASD), including deficits in social communication and interaction, as well as distinct patterns of repetitive behaviors, interests and activities. It will also discuss ASD and developmental screening and explore optimal approaches to care following a diagnosis.
Category
  • Behavioral health
Format
  • Online Education
Credits
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 PRC-CPD - Philippine Professional Nursing
  • 1.00 ASWB - Social Workers
Schizophrenic Patients on Long-term Oral/Topical Antipsychotic Treatment Without a Trial of Atypical Long-acting Injectable Therapy: A Tenncare Initiative
TennCare, in collaboration with Optum Rx, developed a multimodal program focused on encouraging LAI antipsychotic utilization and improving outcomes for patients with schizophrenia. This E-newsletter will provide an overview of the program, including details regarding the benefits of LAI atypical antipsychotics and other available agents, a brief review of schizophrenia and potential clinical steps. Additional information regarding the retrospective drug utilization review process and the rationale for brand drug preference will also be highlighted.
Category
  • Behavioral health
Format
  • Online Education
Credits
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance

Pages